Dr. Reddy’s Laboratories (NYSE:RDY) has launched Doxercalciferol Injection, 4 mcg/2 mL (2 mcg/mL) Multiple-Dose Vials, the therapeutic generic equivalent of Sanofi-Aventis' Hectorol (doxercalciferol) ...

About Dr. Reddy’s: Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for ...

Lupin’s Doxercalciferol Injection, 4 mcg/2 mL (2 mcg/mL) multi-dose vial is the generic version of Genzyme’s Hectorol Injection. It is indicated for the treatment of secondary hyperparathyroidism in ...

Dr. Reddy’s is launching doxercalciferol injection, in 4 mcg/2 mL multidose vials. The product is the generic of Sanofi-Aventis’ Hectorol (doxercalciferol) injection 4 mcg/2 mL (2 mcg/mL) ...

New Delhi, Nov 5 (PTI) Drug firm Lupin Monday said it has received approval from the US health regulator to market its generic Doxercalciferol injection in the American market. The company has ...

Sept. 28, 2005 ( updated Oct. 6, 2005) -- The U.S. Food and Drug Administration (FDA) approved safety labeling revisions in June to advise that doxercalciferol dose reductions are recommended in ...

Doxercalciferol 2mcg/mL; soln for IV inj. Give by IV bolus inj. Dialysis: initially 4mcg three times weekly after dialysis; titrate dose to maintain desired iPTH therapeutic range and serum calcium ...

Middleton-based Bone Care International Inc. said Monday that one of its contracted pharmaceutical manufacturers has received federal approval to produce its kidney disease and osteoporosis drug. Bone ...